LAPSE:2023.6013
Published Article
LAPSE:2023.6013
Preparation of Ophthalmic Microemulsions Containing Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation
Kristina Perminaite, Mindaugas Marksa, Liudas Ivanauskas, Kristina Ramanauskiene
February 23, 2023
Abstract
Royal jelly is a natural substance secreted by worker honeybees that possesses antioxidant, anti-inflammatory, and other biological activities. The purpose of this study was to formulate microemulsions with incorporated Lithuanian royal jelly for possible ophthalmic delivery and to evaluate the quality of the microemulsions in vitro. The oil in water type microemulsions were prepared by the oil titration method, incorporating royal jelly, surfactant, co-surfactant, oil, and water. Physicochemical characteristics of the microemulsions and the quantity of 10-hydroxy-2-decenoic acid released in vitro were assessed. The in vitro assessment of prepared microemulsions formulations was performed with the Statens Seruminstitut rabbit cornea (SIRC) cell culture model. The results revealed that the droplet size of all microemulsion formulations was 67.88−124.2 nm and the polydispersity index was lower than 0.180. In the in vitro release study, the release of 10-hydroxy-2-decenoic acid depended on the amount of royal jelly incorporated and on the ratio of surfactant and co-surfactant in formulations. The in vitro tests with the SIRC cell culture line have shown that all formulations were found non-irritating.
Keywords
10-hydroxy-2-decenoic acid, dry-eye syndrome, eye drops, microemulsion, royal jelly, Statens Seruminstitut rabbit cornea cell line
Subject
Suggested Citation
Perminaite K, Marksa M, Ivanauskas L, Ramanauskiene K. Preparation of Ophthalmic Microemulsions Containing Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation. (2023). LAPSE:2023.6013
Author Affiliations
Perminaite K: Department of Clinical Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukileliu Ave. 13, 50162 Kaunas, Lithuania; Faculty of Pharmacy, Institute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Sukileliu
Marksa M: Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, Sukileliu Ave. 13, 50162 Kaunas, Lithuania
Ivanauskas L: Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, Sukileliu Ave. 13, 50162 Kaunas, Lithuania
Ramanauskiene K: Department of Clinical Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukileliu Ave. 13, 50162 Kaunas, Lithuania
Journal Name
Processes
Volume
9
Issue
4
First Page
616
Year
2021
Publication Date
2021-03-31
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr9040616, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2023.6013
This Record
External Link

https://doi.org/10.3390/pr9040616
Publisher Version
Download
Files
Feb 23, 2023
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
356
Version History
[v1] (Original Submission)
Feb 23, 2023
 
Verified by curator on
Feb 23, 2023
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2023.6013
 
Record Owner
Auto Uploader for LAPSE
Links to Related Works
Directly Related to This Work
Publisher Version
(0.07 seconds)

[0.08 s]